key: cord-0766953-vxxkmiup
authors: JASSAT, W.; Abdool Karim, S.; Mudara, C.; Welch, R.; Ozougwu, L.; Groome, M.; Govender, N.; von Gottberg, A.; Wolter, N.; Wolmarans, M.; Rousseau, P.; Blumberg, L.; Cohen, C.
title: Clinical severity of COVID-19 patients admitted to hospitals during the Omicron wave in South Africa
date: 2022-02-23
journal: nan
DOI: 10.1101/2022.02.22.21268475
sha: c8b0313bd1246a6ace64cc5d6670b4c89256babf
doc_id: 766953
cord_uid: vxxkmiup

Background: Clinical severity of patients hospitalised with SARS-CoV-2 infection during the Omicron (fourth) wave was assessed and compared to trends in the D614G (first), Beta (second), and Delta (third) waves in South Africa. Methods: Weekly incidence of 30 laboratory-confirmed SARS-CoV-2 cases/100,000 population defined the start and end of each wave. Hospital admission data were collected through an active national COVID-19-specific surveillance programme. Disease severity was compared across waves by post-imputation random effect multivariable logistic regression models. Severe disease was defined as one or more of acute respiratory distress, supplemental oxygen, mechanical ventilation, intensive-care admission or death. Results: 335,219 laboratory-confirmed SARS-CoV-2 admissions were analysed, constituting 10.4% of 3,216,179 cases recorded during the 4 waves. In the Omicron wave, 8.3% of cases were admitted to hospital (52,038/629,617) compared to 12.9% (71,411/553,530) in the D614G, 12.6% (91,843/726,772) in the Beta and 10.0% (131,083/1,306,260) in the Delta waves (p<0.001). During the Omicron wave, 33.6% of admissions experienced severe disease compared to 52.3%, 63.4% and 63.0% in the D614G, Beta and Delta waves (p<0.001). The in-hospital case fatality ratio during the Omicron wave was 10.7%, compared to 21.5%, 28.8% and 26.4% in the D614G, Beta and Delta waves (p<0.001). Compared to the Omicron wave, patients had more severe clinical presentations in the D614G (adjusted odds ratio [aOR] 2.07; 95% confidence interval [CI] 2.01-2.13), Beta (aOR 3.59; CI: 3.49-3.70) and Delta (aOR 3.47: CI: 3.38-3.57) waves. Conclusion: The trend of increasing cases and admissions across South Africa's first three waves shifted in Omicron fourth wave, with a higher and quicker peak but fewer admitted patients, who experienced less clinically severe illness and had a lower case-fatality ratio. Omicron marked a change in the SARS-CoV-2 epidemic curve, clinical profile and deaths in South Africa. Extrapolations to other populations should factor in differing vaccination and prior infection levels.

The fifth SARS-CoV-2 variant of concern, Omicron (B.1.1.529 lineage), was first publicly announced in South Africa on 25 November 2021 (1) . Within days, Omicron led to a resurgence of SARS-CoV-2 cases in South Africa and several other countries (2) .

Genomic sequencing revealed that 86% (n=1,353) and 99% (n=1,361) of sequenced SARS-CoV-2 samples nationally in South Africa were Omicron in November and December respectively (3) . The proportion of ThermoFisher TaqPath COVID-19 real-time reverse transcription polymerase chain reaction (rRT-PCR) positive tests with S-gene target failure, a marker of Omicron (4) , was 2% (n=11), 95% (n=10,536) and 98% (n=19,174) in October, November and December respectively (5) .

Phylogenetic surveillance showed that the predominant variants (>90% of viral sequences) during South Africa's first, second and third waves were the ancestral strain with a D614G mutation, Beta and Delta respectively (3) .

The mutations identified in Omicron suggested that it would likely be highly transmissible with immune escape but provided no indication on whether it would have a different clinical severity profile compared to previous variants (1) . Clinical severity of COVID-19 is influenced by several factors besides virulence of the viral variant, including age, sex, race, co-morbidities, vaccination status, immunity from previous SARS-CoV-2 infection and early therapy/prophylaxis. The South African COVID-19 vaccination programme began with healthcare workers from February 2021. It subsequently expanded to adults older than 60 years in May 2021 and then progressively over time to other age groups until adolescents 12-17 years were included in mid-October 2021. As a result, vaccination coverage was low during the Delta wave but by 17 November 2021 before the Omicron wave started, 35% of South Africa's adult population were fully vaccinated with either two doses of BNT162b2 or one dose of Ad26.CoV2.S vaccine (8). A third dose of BNT162b2 and a second dose of Ad26.CoV2.S only became available at the tail end of the Omicron wave. Further, a substantial number of people have been infected with SARS-CoV-2 during each wave. SARS-CoV-2 seroprevalence was 47% in blood donors in South Africa after the second wave (6), and 73% in a community-based survey in Gauteng province after the third wave (7) . Early treatment with Remdesivir or monoclonal antibodies is not widely available and is infrequently used in South Africa.

We assessed the clinical severity of patients hospitalised with laboratory-confirmed SARS-CoV-2 infection during the Omicron wave and whether it differed from the D614G, Beta and Delta waves in South Africa.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Data on real-time reverse transcription polymerase chain reaction (rRT-PCR) and antigen positive SARS-CoV-2 cases were collated daily from laboratory reports (9) while data on COVID-19 hospital admissions were collected through DATCOV, an active surveillance programme established specifically for COVID-19 (10) . Secondary data analysis was conducted using the DATCOV national hospital surveillance database between 5 March 2020 and 22 January 2022. DATCOV surveillance collects data on all individuals with a positive SARS-CoV-2 rRT-PCR test or antigen test, with a confirmed duration of stay in hospital of one full day or longer, regardless of reason for admission. This included patients who had COVID-19 symptoms, were admitted for isolation, acquired nosocomial COVID-19 infection, or tested positive incidentally when admitted for other reasons.

Incidental positive SARS-CoV-2 tests have been noted to occur mainly during the initial period when cases are rising in all four waves in South Africa. Some of the patients admitted in a wave may have been admitted in the previous waves; these repeat admissions (more than 90 days after the first positive SARS-CoV-2 test) were included in the analysis. Incidence risks were calculated using Statistics South Africa mid-year population figures for 2020 (11) .

The wave periods were defined from the week the country crossed a weekly incidence risk of 30 cases per 100,000 persons at the start and end of the waves (12) (13) . The Omicron-dominated wave crossed the weekly incidence risk threshold in the last week of November 2021. The start of each of these four wave periods selected also correlated with the majority of cases being due to the D614G, Beta, Delta and Omicron variants respectively (3). The full wave periods were included for all four waves. Analysis of severity was restricted to admissions that had already accumulated outcomes and all patients still in-hospital or transferred to other hospitals without final outcomes were excluded, because they remained at risk of still developing severe outcomes including death. Descriptive statistics were used to describe the trends in cases, admissions, severe disease and death over the equivalent periods of the D614G (first), Beta (second), Delta (third) and Omicron (fourth) waves.

Post-imputation random effect (on admission facility) multivariable logistic regression models were used to compare severe disease between the waves. To account for incomplete or missing data on selected variables, we used multivariate imputation by chained equation (MICE) and generated ten complete imputed datasets that were used for subsequent analyses. Variables analysed using MICE included race and comorbidities, where up to a third of the data were missing. Complete or near-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint complete variables included in the imputation process were age, sex, province, health sector (i.e. public or private), severity and in-hospital outcome (i.e. discharged alive or died).

Severe disease was defined as one or more of the following: development of acute respiratory distress syndrome, receipt of oxygen or invasive mechanical ventilation, treatment in high-care or intensive-care units (ICUs) or death, using a modified definition based on the recommendations from the World Health Organization (WHO) Clinical Platform External Clinical Advisory Group (14). Age, sex, race, presence of a comorbidity (which included hypertension, diabetes, chronic cardiac disease, chronic kidney disease, asthma/chronic pulmonary disease, malignancy, HIV or tuberculosis), type of health sector (private or public) and province were included in the model to assess the relationship between each wave period and severity in SARS-CoV-2 positive patients admitted to hospital. The presence of obesity, while important, was excluded from the analysis due to poor completeness of this variable. The statistical analysis was implemented using Stata 15 (Stata Corp®, College Station, Texas, USA). We followed STROBE guideline recommendations.

South Africa experienced four distinct waves of SARS-CoV-2 infections, with approximately threemonth periods of low transmission between each wave ( Figure 1 ). The 7-day moving average of daily cases had a peak that was higher in each successive peak of the four waves. While the wave duration increased across the first three waves, it declined in the fourth wave. The number of SARS-CoV-2 positive cases identified during each wave was 553,530, 726,772, 1,306,260 and 629,617 in the D614G, Beta, Delta and Omicron waves respectively (Table 1) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. [3] [4] [5] [6] [7] [8] [9] [10] [11] in the D614G, Beta and Delta waves respectively (p<0.001) ( Table 2 ). The inhospital case fatality ratio during the Omicron wave (Table 1) was 10.7%, compared to 21.5%, 28.8% and 26.4% in the D614G, Beta and Delta waves respectively (p<0.001).

Children and adolescents aged <20 years constituted 14.3% (7,467/52,038) of total admissions in the fourth wave, compared to 3.3% (2,362/71,411), 3.0% (2,801/91,843), and 5.5% (7,156/131,083) in the D614G, Beta and Delta waves. In children <5 years, 25.4% (3,568/14,050) of laboratory-confirmed cases were admitted in the Omicron wave compared to 14.7% (2,797/19,019) in the Delta wave, but the number of children <5 years hospitalised was similar in both waves and were in turn higher than the number of children hospitalised in the D614G and Beta waves ( Table 3) . Other factors associated with severe disease in this patient population were older age, male sex, Indian compared to white race, presence of a comorbidity and the province of admission.

The Omicron wave had a lower proportion of SARS-CoV-2 cases admitted to hospital while those admitted had shorter hospital stays and less severe illness, with fewer requiring oxygen or intensive care treatment compared to the D614G, Beta or Delta waves in South Africa. Both disease severity and in-hospital case fatality ratio were at least 2-fold higher in the three previous waves compared to the Omicron wave. The change in disease severity was more marked in adults than children.

The number of adults aged ≥ 20 years admitted to hospital was substantially lower in the Omicron wave compared to past waves leading to lower clinical burdens in health care services. The patients admitted during the Omicron wave placed less demand on oxygen supplies, ventilators and ICU beds than patients in the previous waves. Early reports from other countries also suggest reduced severity among hospital admissions in the Omicron wave (15,16).

The admission rate was higher in the largely unvaccinated <20 years age group, especially in children aged <5 years, in the Omicron wave compared to the first three waves. However, the admitted children <5 years had less severe illness in the Omicron wave compared to the first three waves.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint Early reports from the United Kingdom also indicate an increased admission rate but decreased severity among children in the Omicron wave (17). Possible reasons for the higher admission rate in children could be that higher transmissibility led to more infections in children, more incidental infection amongst children admitted for other reasons, or their lower rates of prior infection (7) and/or vaccination (8).

The lower admission rates and less severe infections in admitted patients during the Omicron wave are most likely to be due to a combination of a less virulent virus, immunity from vaccination and prior infection(s), especially the large numbers of vaccinated individuals who had prior infection and so have "hybrid immunity" (18) . Tissue-based studies showed that Omicron infects the cells of the bronchus more efficiently but alveolar cells of the lungs less efficiently than the Delta variant (19, 20) . One of the limitations of this study is that clinical outcomes are not known for 11% of patients in the Omicron wave as it ended at the time of analysis and some patients are still in hospital. As clinical . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. 

The trend of increasing cases and admissions across South Africa's first three waves shifted in the Omicron fourth wave. The Omicron wave was characterised by a higher and quicker peak but fewer admitted patients, who experienced less clinically severe illness and had a lower case-fatality ratio.

Omicron marked a change in the SARS-CoV-2 epidemic curve, clinical profile and deaths in South Africa. Early reports from several other countries also indicate less severe disease with Omicron, despite the differences in population structure, co-morbidity prevalence, prevalence of prior infection and vaccination coverage. Since each of the five variants of concern have evolved independently of each other, it remains speculative in the absence of data as to whether the next variant will follow the trend of greater severity seen progressively with the first three waves or follow the low severity observed with Omicron. Data from a well-developed surveillance system for variant identification and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint hospital admissions is essential as part of pandemic preparedness to rapidly investigate the impact of new SARS-CoV-2 variants and viruses causing future pandemics.

DATCOV as a national surveillance system, is funded by the National Institute for Communicable Diseases (NICD) and the South African National Government. No additional funding was obtained towards the completion of this analysis and the development of this manuscript. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

We acknowledge the National Institute for Communicable Diseases (NICD) team responsible for reporting test, case and hospitalisation data. Thanks to the National Department of Health for implementation support and access to vaccination rates (in particular Tania Van der Merwe), the NICD for support and oversight, and the Network for Genomics Surveillance in South Africa (NGS-SA) for sequence frequencies. Our gratitude to the laboratories, clinicians and data teams in all public and private sector hospitals throughout the country reporting cases and hospitalisation data, who are acknowledged and listed as the DATCOV author group: https://www.nicd.ac.za/diseases-a-zindex/covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ 

The dataset analysed for the manuscript is available upon reasonable request. The data dictionary is available at request to the corresponding author: waasilaj@nicd.ac.za

The authors declare that there are no conflicts of interest.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 23, 2022. ; https://doi.org/10.1101/2022.02.22.21268475 doi: medRxiv preprint

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. medRxiv

SARS-CoV-2 Genomic Surveillance Update

Track Omicron's spread with molecular data

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. The Lancet

South African Population Immunity and Severe Covid-19 with Omicron Variant. medRxiv

COVID-19 South African Online Portal

DATCOV: A sentinel surveillance programme for hospitalised individuals with COVID-19 in South Africa, 2020. COVID-19 Special Public Health Surveillance Bulletin

Mid-year population estimates, 2020. Statistical release PO302

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 12. National Institute for Communicable Diseases. Proposed definition of COVID-19 wave in South Africa

Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study

CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2). medRxiv 2021

Reduced risk of hospitalisation associated with infection with SARS-CoV-2 Omicron relative to Delta: A Danish cohort study

Public Health England; SARS-CoV-2 variants of concern and variants under investigation in England

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo

SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion

SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19

Omicron virus causes attenuated infection and disease in mice and hamsters

05 comparing Omicron wave to the D614G, Beta and Delta waves

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 23, 2022.